Siemens Healthineers Competitors

Olink Holding AB (publ) (NASDAQ:OLK) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Valuation and Earnings

This table compares Olink Holding AB (publ) and Siemens Healthineers' gross revenue, earnings per share and valuation.

Profitability

This table compares Olink Holding AB (publ) and Siemens Healthineers' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Olink Holding AB (publ) and Siemens Healthineers, as reported by MarketBeat.

Summary

Siemens Healthineers beats Olink Holding AB (publ) on 1 of the 1 factors compared between the two stocks.

Ortho Clinical Diagnostics (NASDAQ:OCDX) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Earnings & Valuation

This table compares Ortho Clinical Diagnostics and Siemens Healthineers' top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Ortho Clinical Diagnostics and Siemens Healthineers' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Ortho Clinical Diagnostics and Siemens Healthineers, as reported by MarketBeat.com.

Ortho Clinical Diagnostics presently has a consensus price target of $24.2727, indicating a potential upside of 30.22%. Given Ortho Clinical Diagnostics' stronger consensus rating and higher probable upside, research analysts plainly believe Ortho Clinical Diagnostics is more favorable than Siemens Healthineers.

Summary

Ortho Clinical Diagnostics beats Siemens Healthineers on 3 of the 3 factors compared between the two stocks.

Siemens Healthineers (OTCMKTS:SMMNY) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Siemens Healthineers and Biodesix, as reported by MarketBeat.

Biodesix has a consensus target price of $26.00, indicating a potential upside of 37.13%. Given Biodesix's stronger consensus rating and higher possible upside, analysts plainly believe Biodesix is more favorable than Siemens Healthineers.

Profitability

This table compares Siemens Healthineers and Biodesix's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Siemens Healthineers and Biodesix's gross revenue, earnings per share and valuation.

Summary

Biodesix beats Siemens Healthineers on 2 of the 3 factors compared between the two stocks.

Lucira Health (NASDAQ:LHDX) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Profitability

This table compares Lucira Health and Siemens Healthineers' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Lucira Health and Siemens Healthineers' gross revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Lucira Health and Siemens Healthineers, as reported by MarketBeat.

Lucira Health currently has a consensus target price of $9.00, suggesting a potential downside of 1.10%. Given Lucira Health's higher possible upside, equities research analysts plainly believe Lucira Health is more favorable than Siemens Healthineers.

Summary

Siemens Healthineers beats Lucira Health on 2 of the 3 factors compared between the two stocks.

Inotiv (NASDAQ:NOTV) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Valuation & Earnings

This table compares Inotiv and Siemens Healthineers' top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Inotiv and Siemens Healthineers' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and price targets for Inotiv and Siemens Healthineers, as reported by MarketBeat.

Summary

Siemens Healthineers beats Inotiv on 1 of the 1 factors compared between the two stocks.

Siemens Healthineers (OTCMKTS:SMMNY) and Akumin (NASDAQ:AKU) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Siemens Healthineers and Akumin, as provided by MarketBeat.com.

Profitability

This table compares Siemens Healthineers and Akumin's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Siemens Healthineers and Akumin's top-line revenue, earnings per share and valuation.

Insider & Institutional Ownership

30.4% of Akumin shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Akumin beats Siemens Healthineers on 2 of the 3 factors compared between the two stocks.